OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19
Thomas Bieber, Eugen Feist, Alan D. Irvine, et al.
Advances in Therapy (2022) Vol. 39, Iss. 11, pp. 4910-4960
Open Access | Times Cited: 37
Thomas Bieber, Eugen Feist, Alan D. Irvine, et al.
Advances in Therapy (2022) Vol. 39, Iss. 11, pp. 4910-4960
Open Access | Times Cited: 37
Showing 26-50 of 37 citing articles:
Emerging role of baricitinib in dermatology practice: All we need to know!
S. Dogra, Shikha Shah, Ayush Sharma, et al.
Indian Dermatology Online Journal (2023) Vol. 14, Iss. 2, pp. 153-153
Open Access | Times Cited: 2
S. Dogra, Shikha Shah, Ayush Sharma, et al.
Indian Dermatology Online Journal (2023) Vol. 14, Iss. 2, pp. 153-153
Open Access | Times Cited: 2
Does baricitinib reduce disease activity in patients with systemic lupus erythematosus? A systematic review and meta-analysis of randomized controlled trials
Basma Ehab Amer, Eslam Afifi, Adel Mouffokes, et al.
Clinical Rheumatology (2023) Vol. 43, Iss. 2, pp. 579-589
Closed Access | Times Cited: 2
Basma Ehab Amer, Eslam Afifi, Adel Mouffokes, et al.
Clinical Rheumatology (2023) Vol. 43, Iss. 2, pp. 579-589
Closed Access | Times Cited: 2
Shaping the future of antiviral Treatment: Spotlight on Nucleobase-Containing drugs and their revolutionary impact
Xi Khai Wong, Chen Seng Ng, Keng Yoon Yeong
Bioorganic Chemistry (2024) Vol. 144, pp. 107150-107150
Open Access
Xi Khai Wong, Chen Seng Ng, Keng Yoon Yeong
Bioorganic Chemistry (2024) Vol. 144, pp. 107150-107150
Open Access
Successful treatment of actinic prurigo with baricitinib in an 8‐year‐old child: A case report
Mohammad Malekan, Nessa Aghazadeh, Ghasem Rahmatpour Rokni, et al.
Pediatric Dermatology (2024) Vol. 41, Iss. 6, pp. 1159-1161
Closed Access
Mohammad Malekan, Nessa Aghazadeh, Ghasem Rahmatpour Rokni, et al.
Pediatric Dermatology (2024) Vol. 41, Iss. 6, pp. 1159-1161
Closed Access
A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Health Care System
Christian J Song, Christopher Riley, Bart D Wilkison, et al.
Military Medicine (2024)
Closed Access
Christian J Song, Christopher Riley, Bart D Wilkison, et al.
Military Medicine (2024)
Closed Access
What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?
Peter C. Taylor, Eugen Feist, Janet Pope, et al.
Therapeutic Advances in Musculoskeletal Disease (2024) Vol. 16
Open Access
Peter C. Taylor, Eugen Feist, Janet Pope, et al.
Therapeutic Advances in Musculoskeletal Disease (2024) Vol. 16
Open Access
Baricitinib in the treatment of systemic lupus erythematosus: a systematic review of randomized controlled trials
Hussain Haider Shah, Faiza Ashfaque, Zeenat Hadi, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 8, pp. 4738-4744
Open Access
Hussain Haider Shah, Faiza Ashfaque, Zeenat Hadi, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 8, pp. 4738-4744
Open Access
The safety and efficacy of Baricitinib for systemic lupus erythematosus: a systematic review and meta-analysis of randomized controlled trials
Alaa Ramadan, Ibrahim Gowaily, Othman Saleh, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 11, pp. 6673-6685
Open Access
Alaa Ramadan, Ibrahim Gowaily, Othman Saleh, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 11, pp. 6673-6685
Open Access
Efficacy and safety of baricitinib in rheumatoid arthritis patients with moderate renal impairment: a multicenter propensity score matching study
Akira Maeyama, Masakazu Kondo, Hiroshi Harada, et al.
BMC Rheumatology (2024) Vol. 8, Iss. 1
Open Access
Akira Maeyama, Masakazu Kondo, Hiroshi Harada, et al.
BMC Rheumatology (2024) Vol. 8, Iss. 1
Open Access
Outcomes in COVID-19 Patients with Pneumonia Treated with High-Flow Oxygen Therapy and Baricitinib—Retrospective Single-Center Study
Dušanka Obradović, Milica Popović, Maja Banjac, et al.
Life (2023) Vol. 13, Iss. 3, pp. 755-755
Open Access | Times Cited: 1
Dušanka Obradović, Milica Popović, Maja Banjac, et al.
Life (2023) Vol. 13, Iss. 3, pp. 755-755
Open Access | Times Cited: 1
Cancer drugs with high repositioning potential for Alzheimer’s disease
Jad Majeed, Marwan N. Sabbagh, Min H. Kang, et al.
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 4, pp. 311-332
Closed Access | Times Cited: 1
Jad Majeed, Marwan N. Sabbagh, Min H. Kang, et al.
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 4, pp. 311-332
Closed Access | Times Cited: 1
Fresh Baked: An Overview of Newly FDA-Approved Drugs for Dermatological Usage
Bartika Sikder, Abheek Sil
Indian Journal of Dermatology (2023) Vol. 68, Iss. 6, pp. 707-720
Open Access
Bartika Sikder, Abheek Sil
Indian Journal of Dermatology (2023) Vol. 68, Iss. 6, pp. 707-720
Open Access
